Genetic factors influencing cytarabine therapy

Por Lamba, Jatinder K
Publicado em 2009

Identification of suitable reference genes for hepatic microRNA quantitation

Por Lamba, Vishal, Ghodke-Puranik, Yogita, Guan, Weihua, Lamba, Jatinder K
Publicado em 2014

PharmGKB summary: very important pharmacogene information for CYP2B6

Por Thorn, Caroline F., Lamba, Jatinder K., Lamba, Vishal, Klein, Teri E., Altman, Russ B.
Publicado em 2010

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients

Por Bhise, Neha S., Chauhan, Lata, Shin, Miyoung, Cao, Xueyuan, Pounds, Stanley, Lamba, Vishal, Lamba, Jatinder K.
Publicado no Front Pharmacol (2016)

Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity

Por Chauhan, Lata, Jenkins, Gregory D., Bhise, Neha, Feldberg, Tanya, Mitra-Ghosh, Taraswi, Fridley, Brooke L., Lamba, Jatinder K.
Publicado no BMC Genomics (2015)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence

Por Fridley, Brooke L., Ghosh, Taraswi M., Wang, Alice, Raghavan, Rama, Dai, Junqiang, Goode, Ellen L., Lamba, Jatinder K.
Publicado no Front Genet (2016)

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML

Por Lamba, Jatinder K., Pounds, Stanley, Cao, Xueyuan, Downing, James R., Campana, Dario, Ribeiro, Raul C., Pui, Ching-Hon, Rubnitz, Jeffrey E.
Publicado em 2008

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity

Por Hartford, Christine M., Duan, Shiwei, Delaney, Shannon M., Mi, Shuangli, Kistner, Emily O., Lamba, Jatinder K., Huang, R. Stephanie, Dolan, M. Eileen
Publicado em 2009

Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy

Por Puranik, Yogita Ghodke, Birnbaum, Angela K, Marino, Susan E, Ahmed, Ghada, Cloyd, James C, Remmel, Rory P, Leppik, Ilo E, Lamba, Jatinder K
Publicado em 2013

Valproic acid pathway: pharmacokinetics and pharmacodynamics

Por Ghodke-Puranik, Yogita, Thorn, Caroline F., Lamba, Jatinder K., Leeder, J. Steven, Song, Wen, Birnbaum, Angela K., Altman, Russ B., Klein, Teri E.
Publicado em 2013

A Therapeutic Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Por Burke, Michael J., Lamba, Jatinder K, Pounds, Stanley, Cao, Xueyuan, Ghodke-Puranaik, Yogita, Lindgren, Bruce R., Weigel, Brenda J., Verneris, Michael R., Miller, Jeffrey S.
Publicado em 2014

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia

Por Laszlo, George S., Harrington, Kimberly H., Gudgeon, Chelsea J., Beddoe, Mary E., Fitzgibbon, Matthew P., Ries, Rhonda E., Lamba, Jatinder K., McIntosh, Martin W., Meshinchi, Soheil, Walter, Roland B.
Publicado no Oncotarget (2016)

The Influence of CYP3A5 Genotype on Dexamethasone Induction of CYP3A Activity in African Americans

Por Roberts, Patrick J., Rollins, Kristan D., Kashuba, Angela D. M., Paine, Mary F., Nelsen, Andrew C., Williams, Eric E., Moran, Cassandra, Lamba, Jatinder K, Schuetz, Erin G., Hawke, Roy L.
Publicado em 2008

Clinical significance of In vivo Cytarabine Induced Gene Expression Signature in AML

Por Lamba, Jatinder K., Pounds, Stanley, Cao, Xueyuan, Crews, Kristine R., Cogle, Christopher R., Bhise, Neha, Raimondi, Susana C., Downing, James R., Baker, Sharyn D., Ribeiro, Raul C., Rubnitz, Jeffrey E.
Publicado no Leuk Lymphoma (2015)

Intestinal CYP3A4 and Midazolam Disposition in vivo Associate with VDR Polymorphisms and Show Seasonal Variation

Por Thirumaran, Ranjit K., Lamba, Jatinder K., Kim, Richard B., Urquhart, Brad L., Gregor, Jamie C., Chande, Nilesh, Fan, Yiping, Qi, An, Cheng, Cheng, Thummel, Kenneth E., Hall, Stephen D., Schuetz, Erin G.
Publicado em 2012

RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients

Por Cao, Xueyuan, Mitra, Amit K, Pounds, Stanley, Crews, Kristine R, Gandhi, Varsha, Plunkett, William, Dolan, M Eileen, Hartford, Christine, Raimondi, Susana, Campana, Dario, Downing, James, Rubnitz, Jeffrey E, Ribeiro, Raul C, Lamba, Jatinder K
Publicado em 2013

Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians

Por Brown, Kevin C, Hosseinipour, Mina C, Hoskins, Janelle M, Thirumaran, Ranjit K, Tien, Hsiao-Chuan, Weigel, Ralf, Tauzie, Jean, Shumba, Ida, Lamba, Jatinder K, Schuetz, Erin G, McLeod, Howard L, Kashuba, Angela DM, Corbett, Amanda H
Publicado em 2011

CYP2C9*1B Promoter Polymorphisms, in Linkage with CYP2C19*2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose

Por Chaudhry, Amarjit S., Urban, Thomas J., Lamba, Jatinder K., Birnbaum, Angela K., Remmel, Rory P., Subramanian, Murali, Strom, Stephen, You, Joyce H., Kasperaviciute, Dalia, Catarino, Claudia B., Radtke, Rodney A., Sisodiya, Sanjay M., Goldstein, David B., Schuetz, Erin G.
Publicado em 2010

Genetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid Leukemia

Por Mitra, Amit K., Crews, Kristine R., Pounds, Stanley, Cao, Xueyuan, Feldberg, Tanya, Ghodke, Yogita, Gandhi, Varsha, Plunkett, William, Dolan, M. Eileen, Hartford, Christine, Raimondi, Susana, Campana, Dario, Downing, James, Rubnitz, Jeffrey E., Ribeiro, Raul C., Lamba, Jatinder K.
Publicado em 2011

Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes

Por Lamba, Jatinder K, Crews, Kristine R, Pounds, Stanley B, Cao, Xueyuan, Gandhi, Varsha, Plunkett, William, Razzouk, Bassem I, Lamba, Vishal, Baker, Sharyn D, Raimondi, Susana C, Campana, Dario, Pui, Ching-Hon, Downing, James R, Rubnitz, Jeffrey E, Ribeiro, Raul C
Publicado em 2011